|
|
|
|
|
|
|
Arrowhead Pharmaceuticals Inc. (ARWR)
|
|
13.87 0.72 (5.48%)
|
10-16 16:00
|
|
Open:
|
13.04
|
Pre. Close:
|
13.15
|
|
High:
|
14
|
Low:
|
13
|
|
Volume:
|
1,960,471
|
Market Cap:
|
1221M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
13.376 - 13.427
|
13.427 - 13.479
|
|
Low:
|
12.617 - 12.678
|
12.678 - 12.739
|
|
Close:
|
13.051 - 13.145
|
13.145 - 13.239
|
|
|
|
Technical analysis (as of: 2018-10-16 4:10:42 PM)
|
|
Overall:
|
|
|
Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.
|
|
Target:
|
Six months: 20.15  One year: 23.72
|
|
Support:
|
Support1: 12.31 Support2: 10.24
|
|
Resistance:
|
Resistance1:
17.25 Resistance2: 20.31
|
|
Pivot:
|
15.87
|
|
Moving Averages:
|
MA(5): 13.13  MA(20): 16.56
MA(100): 15.11 MA(250): 9.47
|
|
MACD:
|
MACD(12,26):
-1.16 Signal(12,26,9): -0.63
|
|
%K %D:
|
%K(14,3): 13.35 %D(3): 9.60
|
|
RSI:
|
RSI(14): 37.96
|
|
52-Week:
|
High: 22.39
Low: 3.01 Change(%): 255.8
|
|
Average Vol(K):
|
3-Month: 265539
10-Days 493373
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.ARWR has closed above bottom band by 31.9%. Bollinger Bands are 143.7% wider than normal. The large width of the bands suggest high volatility as compared to ARWR's normal range. The bands have been in this wide range for 6 bars. This is a sign that the current trend might continue.
|
|
|
Headline News
|
|
2018-10-16T12:01:00-04:00
Arrowhead Pharmaceuticals Hosts R&D Day on Pipeline of RNAi Therapeutics
2018-10-16T06:14:00-04:00
Johnson & Johnson tops third-quarter earnings, revenue estimates
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
